Pelargonin glycosyltransferase derived from long-styled wild buckwheat and coding gene and application of pelargonin glycosyltransferase

By isolating and cloning pelargonidin glycosyltransferase and its encoding gene from wild buckwheat with long style, the glycosylation of anthocyanins into glycosides was catalyzed, solving the problem of unclear glucosylation reaction at the 3-OH position of pelargonidin in buckwheat, and realizing efficient glycosylation and commercial production.

CN118995655APending Publication Date: 2024-11-22INSTITUTE OF CROP SCIENCE CHINESE ACADEMY OF AGRICULTURAL SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410952908.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-16
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Currently, the glycosylation reaction of anthocyanins in buckwheat, especially the glucosylation reaction at the 3-OH position of pelargonidin, is not well understood, and there is a lack of specific catalytic methods, which affects the biological function of anthocyanins.

Method used

Geraniol glycosyltransferase and its encoding gene were isolated and cloned from wild buckwheat with long style. It was applied to catalyze the glycosylation reaction of anthocyanins to glycosides at the 3-OH position. The enzyme was overexpressed in plants through genetic engineering to achieve the synthesis of 3-O-glucoside of geraniol.

Benefits of technology

This study achieved efficient glycosylation of pelargonidin, providing a novel drug source for the commercial production of pelargonidin glycosides. It is low-cost, green, and safe, and lays the theoretical foundation for the metabolic mechanism of anthocyanins.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995655A_ABST
    Figure CN118995655A_ABST
Patent Text Reader

Abstract

The invention discloses pelargonin glycosyltransferase derived from long-styled wild buckwheat as well as a coding gene and application of the pelargonin glycosyltransferase. A glycosyl transferase coding gene is separated from a long-style wild buckwheat UFGT3 gene cluster, the nucleotide sequence of the glycosyl transferase coding gene is shown as SEQ ID No.1, and the amino acid sequence of the coding protein of the glycosyl transferase coding gene is shown as SEQ ID No.2; genetically transforming the encoding gene of the glycosyl transferase into a buckwheat explant to obtain an overexpressed transgenic buckwheat hairy root; flavonoid metabolites are detected in overexpressed hairy roots of tartary buckwheat, and it is found that the content of pelargonidin-3-O-glucoside is remarkably increased. In-vitro enzyme activity detection and catalytic verification show that the glycosyltransferase effectively converts anthocyanin compounds into corresponding glycosides. By applying the glucosyltransferase provided by the invention, a large amount of corresponding glucoside can be synthesized through an in-vitro bioengineering method, and the glucosyltransferase has the advantages of low cost, efficient process, greenness, safety, no environmental pollution and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to glycosyltransferase and coding gene thereof, in particular to pelargonidin glycosyltransferase and coding gene thereof separated from long-style wild buckwheat (Fagopyrum longistylum). The present invention further relates to application of the glycosyltransferase in catalytic reaction of generating glycoside at 3-OH position of anthocyanidin substances, belonging to the field of pelargonidin glycosyltransferase and coding gene thereof and application thereof. Background Art

[0002] Long-style wild buckwheat is a dicotyledonous plant of the genus Fagopyrum in the Polygonaceae family. It is a wild relative of cultivated buckwheat and contains rich secondary metabolites, such as polyphenols and flavonoids (anthocyanidins, rutin, quercetin, etc.). Among them, anthocyanidin compounds are widely used in the fields of food, medicine, cosmetics, etc., and can be used as food pigments, cosmetic active ingredients, etc. In addition, they also have antioxidant, anti-inflammatory, anti-cancer, and cardiovascular health protection effects, so they are widely used in medicines. Anthocyanidin substances can exist in various forms such as free, bound, metabolites, and polymers in vivo and in vitro, and different forms may play different biological functions and effects in vivo.

[0003] Glycosylation of plant molecules is a common modification reaction of natural compounds in the body, which will form natural glycoside compounds with more stable structures. In glycosylation reactions, glycosyltransferases play an important role in the synthesis and physiological activities of important natural active products in plants, and are common and important downstream modification reactions in the synthesis pathway of plant secondary metabolites. Many important active ingredients in medicinal plants are products of glycosylation, such as pelargonidin, the active ingredient of rhubarb, salidroside, the active ingredient of Rhodiola rosea, quercetin, nicotinoids and astragaloside in buckwheat, etc. However, the metabolic mechanism of various anthocyanidin compounds such as pelargonidin in buckwheat is still unclear, especially the glycosylation reaction of anthocyanidins such as pelargonidin from wild relatives of buckwheat is almost blank. In addition, there has been no report on the specific 3-OH position glucosylation reaction of anthocyanidins such as pelargonidin from wild relatives of buckwheat and its functional application. Summary of the invention

[0004] One of the purposes of the present invention is to provide a pelargonidin glycosyltransferase isolated from long-style wild buckwheat and its encoding gene;

[0005] The second purpose of the present invention is to use the pelargonidin glycosyltransferase isolated from the long-style wild buckwheat and its encoding gene to catalyze the glycosylation reaction of anthocyanidins to generate glycosides at the 3-OH position.

[0006] To achieve the above purpose, the main technical solutions adopted by the present invention include:

[0007] On the one hand, the present invention discloses a pelargonidin glycosyltransferase derived from long-style wild buckwheat, the amino acid sequence of which is shown in SEQ ID No.2:

[0008] MENTSTPHAVLVSSPGMGHLIPVFELSKRLSSLYSFKVTILFVTTQSDDQSSLSQYSLTNVDLLQIPAADISHIVYPGAQAVYKIGVIMRETGPAIRAAI SNLMDPKPEPKPTVLIFDMFATEYVSMGREFGLPNFVYVPCSAWSLALTVYCPVLDKVVEGEYVDQTEPLKIPGWYGKSKEIKDWLDRQPARSVVYVSFG SGGTLSTTQMDELAFGLEMSQQRFVWVVRPPVDGQASASYFGMKGESDDFSKYLPYGFMERTLDVGLLVPKWGPQLEILSHKSIGGFLTHCGWNSVIESITNGVPMIAWPMYAEQKMNARMIVEELKIATRPSELPGKKVVRREEVEKMVRIVLEGDEGYHMRTRAEDFRKSGVQALSESGSSYKSLTKFVFEKTI(SEQ ID No.2).

[0009] Another aspect of the present invention discloses a gene encoding pelargonidin glycosyltransferase from long-style wild buckwheat, the polynucleotide sequence of its CDS is shown in (a), (b) or (c):

[0010] (a) the polynucleotide sequence shown in SEQ ID No. 1;

[0011]

[0012] or (b) a polynucleotide sequence that can hybridize with the complementary sequence of SEQ ID No. 1 under stringent hybridization conditions, and the protein encoded by the polynucleotide still has the function or activity of glycosyltransferase;

[0013] Or (c) a polynucleotide sequence having at least 80% homology with the polynucleotide sequence of SEQ ID No.1, and the protein encoded by the polynucleotide still has the function or activity of glycosyltransferase; preferably, a polynucleotide sequence having at least 85% homology with the polynucleotide sequence of SEQ ID No.1, and the protein encoded by the polynucleotide still has the function or activity of glycosyltransferase; more preferably, a polynucleotide sequence having at least 90% homology with the polynucleotide sequence of SEQ ID No.1, and the protein encoded by the polynucleotide still has the function or activity of glycosyltransferase.

[0014] In another aspect, the present invention provides the use of pelargonidin glycosyltransferase isolated from long-style wild buckwheat for catalyzing the glycosylation reaction of anthocyanidins to generate glycosides at the 3-OH position; wherein the anthocyanidins are preferably pelargonidin.

[0015] As a preferred specific embodiment of the present invention, the pelargonidin glycosyltransferase enzyme catalyzes the conversion of pelargonidin compounds into corresponding glycosides, including: using pelargonidin glycosyltransferase as a catalyst to catalyze the glycosylation reaction of pelargonidin at the 3-OH position to generate glycosides to generate pelargonidin-3-O-glucoside.

[0016] Therefore, the present invention provides a method for converting pelargonidin into corresponding glucoside in vitro, comprising: using pelargonidin glycosyltransferase as a catalytic enzyme to catalyze the glycosylation reaction of pelargonidin to obtain the corresponding glycoside compound.

[0017] In addition, the pelargonidin glycosyltransferase encoding gene isolated by the present invention can also be used to promote the glycosylation reaction of anthocyanidin substances in plants. For example, the pelargonidin glycosyltransferase encoding gene can be operably connected to a plant expression vector to construct a recombinant plant expression vector, and the constructed recombinant plant expression vector is transformed into a plant to obtain an overexpression plant, thereby promoting the glycosylation reaction of anthocyanidin substances in the plant.

[0018] Those skilled in the art can use conventional technical means in the art to obtain recombinant pelargonidin glycosyltransferase by conventional prokaryotic expression or eukaryotic expression methods of the pelargonidin glycosyltransferase encoding gene, and use the recombinant pelargonidin glycosyltransferase to catalyze the glycosylation reaction of anthocyanidin compounds through in vitro conversion or catalysis methods to obtain corresponding glycoside compounds.

[0019] The present invention also discloses a recombinant expression vector containing the pelargonidin glycosyltransferase encoding gene; preferably, the recombinant expression vector can be a recombinant plant expression vector or a recombinant prokaryotic expression vector.

[0020] The present invention further discloses a recombinant host cell or recombinant bacteria containing the pelargonidin glycosyltransferase encoding gene; wherein the recombinant bacteria include but are not limited to recombinant Escherichia coli or recombinant plant cells.

[0021] In the present invention, any plant transformation method can be used to introduce the recombinant plant expression vector constructed by the present invention into the cells, tissues or organs of the target plant to obtain a transformant; then the transformant is regenerated by a plant tissue culture method to obtain a complete plant and its asexual line or its offspring; the transformation methods include: Agrobacterium-mediated transformation, protoplast transformation, Ti plasmid, Ri plasmid, plant virus vector, microinjection, electroporation, microparticle bombardment, etc.

[0022] The chimeric gene or expression cassette obtained by chimerizing or connecting the gene shown in SEQ ID No. 1 of the present invention with other genes belongs to the protection scope of the present invention; the recombinant expression vector containing the chimeric gene or expression cassette also belongs to the protection scope of the present invention.

[0023] The transgenic plant cells and plants obtained by the method disclosed in the present invention can also be further used in subsequent transformation procedures, for example, to introduce other chimeric genes.

[0024] The present invention clones a new glucose transferase gene in the anthocyanidin (pelargonidin) synthesis pathway from long-style wild buckwheat, and names it FlAGT; the present invention further genetically transforms the nucleotide sequence of the glycosyltransferase encoding gene FlAGT into buckwheat explants by genetic engineering means to obtain overexpressed transgenic buckwheat hairy roots; the constructed Halo-FlAGT fusion vector is further used to obtain the Halo-FlAGT protein by a cell-free in vitro expression method, and the in vitro enzyme activity detection and catalytic verification of the recombinant protein are completed. The results show that the glycosyltransferase can efficiently convert the anthocyanidin compound pelargonidin into the corresponding glycoside in vitro, that is, the 3-OH position of pelargonidin is combined with a molecule of glucose in UDP-sugar and specifically modified by addition to generate pelargonidin-3-O-glucoside. Therefore, the application of the glucose transferase provided by the present invention can synthesize the corresponding glycoside of pelargonidin in large quantities through an in vitro bioengineering method, providing a new high-quality drug source for commercial production and utilization of pelargonidin and its glycoside compounds, and the method has reliable effects and low costs; the production process is efficient, green, safe, and has no environmental pollution. The present invention clarifies the functions of glycosylases involved in the biosynthesis of buckwheat anthocyanidins, laying a theoretical foundation for subsequent in-depth research on the metabolic mechanism of anthocyanidin compounds regulated by glycosyltransferases.

[0025] Definitions of terms used in this invention

[0026] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Although any methods, devices and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, preferred methods, devices and materials are now described.

[0027] The term "homology" refers to sequence similarity to a natural nucleic acid sequence. "Homology" includes nucleotide sequences that are preferably 85% or higher, more preferably 90% or higher, and most preferably 95% or higher identical to the nucleotide sequence of the regulatory fragment of the present invention. Homology can be evaluated by the naked eye or by computer software. Using computer software, the homology between two or more sequences can be expressed as a percentage (%), which can be used to evaluate the homology between related sequences.

[0028] The term "complementary" herein refers to two nucleotide sequences including antiparallel nucleotide sequences that can pair with each other after forming hydrogen bonds between the complementary base residues of the antiparallel nucleotide sequences. It is known in the art that the nucleotide sequences of two complementary chains are reverse complementary to each other when both sequences are viewed from the 5' to 3' direction. It is also known in the art that two sequences that can hybridize to each other under a given set of conditions do not necessarily have to be 100% completely complementary.

[0029] The term "stringent hybridization conditions" means conditions of low ionic strength and high temperature as known in the art. Typically, under stringent conditions, the detectable degree of hybridization of a probe to its target sequence is higher than the detectable degree of hybridization to other sequences (e.g., at least 2 times greater than background). Stringent hybridization conditions are sequence-dependent and will be different under different environmental conditions, with longer sequences specifically hybridizing at higher temperatures. By controlling the stringency of hybridization or washing conditions, a target sequence that is 100% complementary to the probe can be identified. For detailed guidance on nucleic acid hybridization, reference may be made to the relevant literature (Tijssen, Techniques in Biochemistry and Molecular Biology-Hybridization with Nucleic Probes," Overview of principles of hybridization and the strategy of nucleic acid assays. 1993). More specifically, the stringent conditions are usually selected to be about 5-10°C lower than the thermal melting point (Tm) of the specific sequence at a specified ionic strength and pH. Tm is the temperature (under specified ionic strength, pH and nucleic acid concentration) at which 50% of the probes complementary to the target hybridize to the target sequence in a state of equilibrium (because the target sequence is present in excess, 50% of the probes are occupied in a state of equilibrium at Tm). The stringent conditions may be the following conditions: wherein at pH 7.0 to 8.3, the salt concentration is less than about 1.0M sodium ion concentration, typically about 0.01 to 1.0M sodium ion concentration (or other salts), and the temperature is at least about 30°C for short probes (including but not limited to 10 to 50 nucleotides) and at least about 60°C for long probes (including but not limited to greater than 50 nucleotides). Stringent conditions can also be achieved by adding destabilizing agents such as formamide. For selective or specific hybridization, a positive signal can be at least two times the background hybridization, optionally 10 times the background hybridization. Exemplary stringent hybridization conditions can be as follows: 50% formamide, 5×SSC and 1% SDS, incubated at 42°C; or 5×SSC, 1% SDS, incubated at 65°C, washed in 0.2×SSC and washed in 0.1% SDS at 65°C. The wash can be performed for 5, 15, 30, 60, 120 minutes or longer.

[0030] The term "host cell" or "recombinant host cell" means a cell comprising a polynucleotide of the present invention, regardless of the method used for insertion to produce a recombinant host cell, such as direct uptake, transduction, f-mating, or other methods known in the art. The exogenous polynucleotide may be maintained as a non-integrating vector such as a plasmid or may be integrated into the host genome.

[0031] The term "polynucleotide" or "nucleotide" means deoxyribonucleotides, deoxyribonucleosides, ribonucleosides or ribonucleotides and polymers thereof in single-stranded or double-stranded form. Unless specifically limited, the term encompasses nucleic acids containing known analogs of natural nucleotides, which have binding properties similar to reference nucleic acids and are metabolized in a manner similar to naturally occurring nucleotides. Unless otherwise specifically limited, the term also means oligonucleotide analogs, which include PNA (peptide nucleic acid), DNA analogs used in antisense technology (phosphorothioate, phosphoramidate, etc.). Unless otherwise specified, a specific nucleic acid sequence also implicitly encompasses conservatively modified variants thereof (including but not limited to degenerate codon substitutions) and complementary sequences as well as explicitly specified sequences. In particular, degenerate codon substitutions can be achieved by generating a sequence in which the 3rd position of one or more selected (or all) codons is substituted with mixed bases and / or deoxyinosine residues.

[0032] The term "operably linked" refers to the functional spatial arrangement of two or more nucleic acid regions or nucleic acid sequences. For example, a promoter region can be positioned relative to a nucleic acid sequence encoding an expression product of interest so that transcription of the nucleic acid sequence is directed by the promoter region. Thus, the promoter region is "operably linked to the nucleic acid sequence."

[0033] The term "transformation" as used herein refers to a process for introducing heterologous DNA into plant cells, plant tissues, or plants. Transformed plant cells, plant tissues, or plants are understood to include not only the end product of the transformation process, but also its progeny.

[0034] The terms "transformed," "transgenic," and "recombinant" herein refer to a host cell or organism, such as a bacterium or plant cell (e.g., a plant), into which a heterologous nucleic acid molecule has been introduced. The nucleic acid molecule may be stably integrated into the host's genome, or the nucleic acid molecule may exist as an extrachromosomal molecule. Such an extrachromosomal molecule may be self-replicating. Transformed cells, tissues, or plants are understood to include not only the end product of the transformation process, but also its transgenic progeny. An "untransformed," "untransgenic," or "unrecombined" host refers to a wild-type organism, such as a bacterium or plant, that does not contain the heterologous nucleic acid molecule.

[0035] The term "promoter" refers to any nucleic acid sequence (such as a DNA sequence) that is recognized and bound (directly or indirectly) by a DNA-dependent RNA polymerase during the initiation of transcription, resulting in the generation of an RNA molecule complementary to the transcribed DNA; this region may also be referred to as a "5' regulatory region". A promoter is typically located upstream of the 5' untranslated region (UTR) present in front of the coding sequence to be transcribed and has multiple regions that serve as binding sites for RNA polymerase II and other proteins such as transcription factors to initiate transcription of operably linked genes. The promoter itself may contain subelements (i.e., promoter motifs) such as cis elements or enhancer domains that regulate the transcription of operably linked genes. The promoter and the connected 5'UTR are also referred to as "promoter regions". BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 This is the cloning result of the CDS of the FIAGT gene.

[0037] Figure 2 This is the identification result of transgenic hairy roots.

[0038] Figure 3 qPCR detection of the relative expression level of the FlAGT gene in transgenic hairy roots and empty A4 hairy roots.

[0039] Figure 4 The results of the detection of pelargonidin-3-O-glucoside content after FlAGT was overexpressed in the hairy roots of buckwheat.

[0040] Figure 5 This is the HPLC chromatogram of the synthesis of pelargonidin-3-O-glucoside by FlAGT glycosyltransferase. DETAILED DESCRIPTION

[0041] The present invention will be further described below in conjunction with specific embodiments, and the advantages and features of the present invention will become clearer as the description proceeds. However, it should be understood that the embodiments are exemplary only and do not constitute any limitation to the scope of the present invention. It should be understood by those skilled in the art that the details and forms of the technical solution of the present invention may be modified or replaced without departing from the spirit and scope of the present invention, but these modifications or replacements all fall within the protection scope of the present invention.

[0042] Example 1 Cloning of F1AGT gene CDS

[0043] In this example, the glycosyltransferase FIAGT gene was cloned from long-style wild buckwheat tissue culture seedlings by gene cloning method and the gene sequence information was analyzed, as follows:

[0044] Select wild long-style buckwheat seedlings with good growth conditions, take 50-100 mg of seedlings, add liquid nitrogen to grind them thoroughly, and use Trizol method to extract total RNA. Use this RNA as a template, and use III 1st Strand cDNA Synthesis Kit (+gDNA wiper) (Nanjing Novozyme Biotechnology Co., Ltd.) for reverse transcription to obtain seedling cDNA.

[0045] Design specific primers according to the CDS sequence of FlAGT:

[0046] FlAGT-F: 5'-ATGGAAAACACCTCAACTCCAC-3' (SEQ ID No. 3), FlAGT-R: 5'-CTATATTGTCTTTTCAAACACA-3' (SEQ ID No. 4);

[0047] PCR amplification was performed using the long-style wild buckwheat cDNA as a template to obtain the CDS sequence of the target gene. Figure 1 .

[0048] The PCR program was 95°C for 3 min, 95°C for 30 s, 58°C for 30 s, 72°C for 90 s, and 34 cycles. The PCR purified product was connected to the pTOPO-Blunt Simpl blunt-end cloning vector to obtain the FlAGT-T vector plasmid.

[0049] Finally, the CDS sequence of the FlAGT gene was cloned and obtained in the present invention. The nucleotide sequence is shown in SEQ ID No.1, and the amino acid sequence of the encoded protein is shown in SEQ ID No.2.

[0050] Example 2 Overexpression of FIAGT gene in Tartary Buckwheat hairy roots and detection of expression level

[0051] The FlAGT gene is operably constructed into the expression control sequence to obtain a plant expression vector pCAMBIA 1300-FlAGT containing the FlAGT gene. Specifically, the construction method of the plant expression vector pCAMBIA 1300-FlAGT includes:

[0052] Homologous recombination primers were designed, and the full-length sequence of FlAGT was amplified by PCR using the FlAGT-T vector as a template and OE-FlAGT-F / R as primers.

[0053] Upstream primer: 1300-FlAGT-F:

[0054] 5'-aacacgggggacgagctcggtaccATGGAAAACACCTCAACTCCAC-3'(SEQ ID No.5)

[0055] Downstream primer: 1300-FlAGT-R:

[0056] 5'-ttcttctcctttgcccatgtcgactctagaTATTGTCTTTTCAAACACAAAC-3' (SEQ ID No. 6).

[0057] After enzyme digestion, recovery and ligation transformation, the full-length sequence of the FlAGT gene was forward inserted into the downstream of the CaMV35S promoter of the pCAMBIA-1300 vector, and the overexpression vector pCAMBIA1300-FlAGT was obtained after complete sequencing.

[0058] The constructed overexpression vector pCAMBIA1300-FlAGT containing the FlAGT gene is transformed into Agrobacterium rhizogenes to obtain an Agrobacterium rhizogenes strain containing the FlAGT gene plant expression vector for transforming tartary buckwheat, specifically comprising: sequencing and verifying the correct pCAMBIA 1300-FlAGT recombinant plasmid, transforming Agrobacterium rhizogenes A4 competent cells by heat shock method, and obtaining pCAMBIA 1300-FlAGT recombinant plasmid positive bacteria after colony PCR identification.

[0059] The pCAMBIA 1300-FlAGT recombinant plasmid positive bacteria were used to infect buckwheat, and transgenic and empty vector hairy roots were cultured, and positive strains were obtained by PCR detection.

[0060] The transgenic hairy roots of tartary buckwheat that were positive by PCR were cloned for PCR detection: the infected hypocotyls and cotyledons of tartary buckwheat were placed on MS solid medium, and after the amount of hairy roots was sufficient, an appropriate amount was taken into MS liquid medium and shaken at room temperature (120r / min) (at the same time, the hairy roots of empty A4 strain were used as positive control, and the hairy roots of A4 empty bacteria were used as negative control). FlAGT-F / R was used to detect gene expression, and the PCR procedure was consistent with that described in Example 1. Figure 2 The results of identification of transgenic hairy roots are shown in Figure 2. The expression level of FlAGT gene in the overexpressed FlAGT-OE hairy roots is higher than that in the hairy roots transformed with A4 empty bacteria ( Figure 3 ).

[0061] Example 3 Detection of pelargonidin 3-O-glucoside content in hairy roots of tartary buckwheat with overexpression of F1AGT gene

[0062] The content of pelargonidin 3-O-glucoside was determined in the three overexpression strains (1, 2, 3) in Example 3.

[0063] The sampled material was dried in a 65℃ oven for 12h, then ground into powder using a mortar, 0.1g of the powder was weighed and dissolved in 10ml of 80% methanol solution. Ultrasonic extraction was performed at 50℃ for 45min. The sample was filtered through a 0.22um organic filter membrane and transferred to a 2ml sample bottle for testing.

[0064] The product was determined by high performance liquid chromatography-mass spectrometry: the concentration of methanol solution was 55-85%, the temperature was 25-60°C, the ultrasonic time was 15-40min, and the ultrasonic frequency was 30-60kHz. The stationary phase was a chromatographic column filled with octadecyl bonded silica gel; the mobile phase was 0.1% formic acid / acetonitrile aqueous solution; the flow rate was 0.5mL / min; the detection wavelength was 210-280nm; the injection volume was 5-20μL; the column temperature was 33-45°C. The extraction procedure was: 10 ml of methanol was added to 0.05g of freeze-dried powder, ultrasonic extraction was performed 3 times, and the extract was filtered through a 0.22μm filter membrane. Chromatographic conditions: C18 column (2.1mm×75mm, 2.7μm). The mobile phase gradient elution program of pelargonidin 3-O-glucoside was 0-7 min, 10%-40% A; 7.5 min, 60% A; 10 min, 60% A; 10.1 min, 10% A; 13.1 min, 10% A. The peak area of ​​pelargonidin 3-O-glucoside was used to quantify the reaction product. Each sample was repeated three times.

[0065] Test results such as Figure 4 As shown. Figure 4 The results show that the content of pelargonidin 3-O-glucoside in the hairy roots of buckwheat overexpressing FlAGT was detected. The results showed that the three overexpression strains significantly increased the content of pelargonidin 3-O-glucoside in the hairy roots compared with the control group (A4). The results indicate that the FlAGT gene is involved in the synthesis pathway of pelargonidin 3-O-glucoside and can positively regulate its biosynthesis.

[0066] Example 4 Synthesis of pelargonidin-3-O-glucoside by F1AGT glycosyltransferase and HPLC Detection

[0067] The catalytic reaction mode of pelargonidin and pelargonidin-3-O-glucoside under the FlAGT glycosyltransferase is as follows: with pelargonidin as a substrate and UDP-glucose as a glycosyl donor, under the catalysis of the FlAGT glucosyltransferase provided by the present invention, a molecule of glucose is added to the 3-OH position of pelargonidin to generate pelargonidin-3-O-glucoside.

[0068] use High-Yield Protein Expression System Cell-free Expression System In vitro Expression of Recombinant pUC57-Halo-FlAGT. First, the Halo-FlAGT recombinant vector was constructed according to the method for constructing a recombinant vector mentioned in Example 2, and the primers were:

[0069] Upstream primer: Halo-FlAGT-F:

[0070] 5'-aggctccgcggccgccATGGAAAACACCTCAACTCCAC-3'(SEQ IDNo.7)

[0071] Downstream primer: Halo-FlAGT-R:

[0072] 5'-aagctgggtcggcgcgccTATTGTCTTTTCAAACACAAAC-3' (SEQ ID No. 8).

[0073] The kit requires a reaction, the reaction system is: SP6 High-Yield Wheat Germ asterlMix 30μL, 2-3μg Halo-FlAGT recombinant vector.

[0074] In vitro enzyme activity detection of recombinant Halo-FlAGT protein: The standard substances are pelargonidin and pelargonidin-3-O-glucoside. Add 2 μg of purified recombinant protein Halo-FlAGT to 200 μL reaction buffer (100 mM Tris-HCl (pH 8.0), 14 mM β-mercaptoethanol, 10 mM UDP-glucose (RYON, RZ1070), 1 mM pelargonidin) and incubate at 37°C for 30 min. After adding 800 μL methanol to terminate the reaction, the product was determined by high performance liquid chromatography-mass spectrometry. The retention time values ​​of the pelargonidin and pelargonidin-3-O-glucoside standards were used to identify the reaction products.

[0075] The product was determined by HPLC-MS:

[0076] The concentration of methanol solution is 55-85%, the temperature is 25-60℃, the ultrasonic time is 15-40min, and the ultrasonic frequency is 30-60kHz. The stationary phase is a chromatographic column filled with octadecyl bonded silica gel; the mobile phase is 0.1% formic acid / acetonitrile aqueous solution; the flow rate is 0.5mL / min; the detection wavelength is 230-280nm; the injection volume is 5-20μL; the column temperature is 33-45℃. A calibration curve was established using liquid chromatography-mass spectrometry (LC-MS / MS), R2=0.9991, R2=0.9995, indicating a good linear relationship. Extraction procedure: 20ml methanol was added to 0.1g of freeze-dried powder, ultrasonic extraction was performed 3 times, and the extract passed through a 0.22μm filter membrane. Chromatographic conditions: C18 column (2.1mm×75mm, 2.7μm). The mobile phase gradient elution program for Em (pelargonidin) and EmG (pelargonidin-3-O-glucoside) was 0-6 min, 10%-30% A; 12 min, 80% A; 15 min, 80% A; 15.1 min, 10% A; 18 min, 10% A. The peak areas of pelargonidin and pelargonidin-3-O-glucoside were used to quantify the reaction products. Each sample was repeated three times.

[0077] The HPLC chromatogram of pelargonidin-3-O-glucoside synthesized by FlAGT glycosyltransferase is as follows: Figure 5 As shown, according to Figure 5 It can be seen that pelargonidin-3-O-glucoside is efficiently converted under the catalysis of Halo-FlAGT.

Claims

1. A pelargonidin glycosyltransferase derived from long-style wild buckwheat (Fagopyrum longistylum), characterized in that: Its amino acid sequence is shown in SEQ ID No.

2.

2. The gene encoding the pelargonidin glycosyltransferase according to claim 1.

3. The coding gene according to claim 2, characterized in that: The CDS polynucleotide sequence of the gene is shown in SEQ ID No.

1.

4. An expression cassette comprising the gene or chimeric gene according to claim 2 or 3.

5. A recombinant expression vector containing the gene according to claim 2 or 3.

6. A recombinant expression vector containing the expression cassette according to claim 4.

7. The recombinant expression vector according to claim 5 or 6, characterized in that: The recombinant expression vector is a recombinant plant expression vector or a prokaryotic expression vector.

8. Use of the pelargonidin glycosyltransferase according to claim 1 in catalyzing the glycosylation reaction of anthocyanidins to generate glycosides at the 3-OH position.

9. The use according to claim 8, characterized in that The anthocyanidin substances include pelargonidin.

10. The use according to claim 8, characterized in that The application includes: using pelargonidin glycosyltransferase as a catalytic enzyme to catalyze the glycosylation reaction of pelargonidin at the 3-OH position to generate pelargonidin-3-O-glucoside.